explore -WSS

explore

author：focus 2025-10-02 15:43:35 - browse：9

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

WSS

The Harvard botanist who searched for psychedelics in the Amazon

A new approach to psychiatric drug development

The Harvard botanist who searched for psychedelics in the Amazon

STAT readers on older presidents, polypills, Medicare, and more

Why palliative psychiatry is worth discussing

Alabama IVF ruling threatens families facing fatal genetic disease

knowledge

explore

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

In utero gene editing: an explainer

23andMe had bad news about my health. I wish a person had delivered it

Harvard's David Sinclair gets blowback over aging

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Change Healthcare: What is it, why does its cyberattack matter?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Immune cells and nerve overgrowth may explain recurring UTI pain

Medical records are filled with copy

New documents shed light on MD Anderson Cancer Institute feud

focus

Florida health officials providing scant details on measles cases

R1 RCM gets $5.8 billion buyout offer from private equity firm

Community Health Systems hospitals under DOJ investigation

R1 RCM gets $5.8 billion buyout offer from private equity firm

Families look for replacement for GSK asthma drug Flovent

First over

leisure time

knowledge

explore

entertainment